[Step-by-step treatment of adult patients].
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
External suppressors, sufS, of a -1 frameshift mutant cause ribosomes to shift into the -1 frame when reading the sequence CAG GGA GUG. The resulting product is not Gln-Gly-Val but Gln-Gly-Ser with Ser being encoded by the underlined AGU. The alleles investigated are approximately 2% efficient in causing frameshifting. Two other suppressors, hopR and hopE of the same -1 frameshift mutant, cause some ribosomes reading the sequence GUG UG to decode a single amino acid, Val, from the five nucleotides. The possibility is considered that peptidyl-tRNA(Val) dissociates from the mRNA, but re-pairs in a triplet manner after the mRNA slips forward by two bases.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The results of therapy of 186 patients with stable arterial hypertension were described. Intervals in therapy for 3 mos and more were recorded in 5.9% of the patients. Monotherapy with one randomly chosen drug turned out possible for one year in 40.9% of the patients. In a group analysis a total antihypertensive effect (complete or partial) was noted in 93.5% of the patients. An individual analysis showed that a stable antihypertensive effect (over 6 mos running for one year) was achieved in 17.7%. A stable and prolonged intermittent effect (for 6 mos during one year with and without interruptions) was achieved in 46.2%. Regular control with relation to AH initial type was recommended: in 3 mos for a mild type, in 1.5 mos for a moderate type, in 0.5 mos in a severe type.
Explore the source record for details and available documents.